Physician profile
Fahad S Gilani
NPI 1184884975
$417,954.99
in general payments reported to CMS, 2019-2025
25 companies · $56K in 2025
The $56K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,489 · 2020: $26K · 2021: $76K · 2022: $101K · 2023: $75K · 2024: $75K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $123K · Consulting Fee: $39K · Travel and Lodging: $28K · Food and Beverage: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,500 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $123,006.25 |
| Consulting Fee | $39,000.00 |
| Travel and Lodging | $28,492.06 |
| Food and Beverage | $11,160.64 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,500.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $297,434.30 | 2021-2025 | Corevalve Evolut R, Apollotm, Abre |
| Abbott Laboratories | $51,896.63 | 2019-2025 | Amplatzer Talisman, Mitraclip, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $33,418.15 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $28,250.72 | 2019-2020 | |
| Cardinal Health 200 LLC | $2,489.60 | 2019 | |
| Inari Medical, INC. | $1,015.88 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $654.40 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $472.72 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $350.08 | 2022 | |
| Boston Scientific Corporation | $313.51 | 2019-2024 | |
| Cardiovascular Systems INC. | $239.62 | 2020 | |
| Abiomed | $233.41 | 2022-2025 | Impella |
| Biotronik INC. | $231.91 | 2021-2024 | Nhancer Rx, Orsiro Mission, Pantera Leo |
| Endotronix, INC. | $193.45 | 2024-2025 | Cordella Pulomonary Artery Pressure Sensor |
| W. L. Gore & Associates, INC. | $153.95 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $102.76 | 2019-2025 | Farxiga, Wainua |
| Alnylam Pharmaceuticals INC. | $87.68 | 2022 | |
| Philips North America LLC | $87.10 | 2020 | |
| Pfizer INC. | $86.17 | 2024-2025 | |
| Opsens INC. | $64.79 | 2021 | |
| Ekos Corporation | $59.30 | 2019 | |
| Novartis Pharmaceuticals Corporation | $50.91 | 2024 | |
| Heartflow, INC. | $29.37 | 2025 | |
| Janssen Pharmaceuticals, INC | $24.41 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.17 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fahad Gilani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.